We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

MXC Mgc Pharmaceuticals Limited

-0.0025 (-3.03%)
02 Oct 2023 - Closed
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.

Share Name Share Symbol Market Type Share ISIN Share Description
Mgc Pharmaceuticals Limited LSE:MXC London Ordinary Share AU000000MXC6 ORD NPV (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.0025 -3.03% 0.08 0.075 0.09 0.0825 0.0825 0.08 3,241,518 16:40:19
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Drug & Proprietary Stores 4.3 -20.8 -0.6 - 3.54

Mgc Pharmaceuticals Share Discussion Threads

Showing 17026 to 17035 of 17525 messages
Chat Pages: Latest  689  688  687  686  685  684  683  682  681  680  679  678  Older
Cheers looney see the inbreds have started a fredz (@English classes required)
Seems a perfectly reasonable view. Thank you.
They need money 💰- can’t build a business without it. If you can’t pay staff you can’t do trials, no trials equals no business. This is a long term hold. At least Mercer are prepare to offer funds albeit in return for a piece of the action. They assume there will be action so no reason why we should think any differently. Just my opinion.
No comments on today's RNS?
More good news:-

7 March 2023 ASX Code: MXC LSE Code: MXC
Completion of CimetrATM Mechanism of Action study
Key Highlights:
• •

• •
TM’s ability
MGC Pharma has completed an in-vitro pre-clinical study on CimetrATM’s mechanism of
action (MoA)
The study, which was carried out at the GLP-Certified Science in Action Lab, in Ness Ziona,
Israel, examined the mechanism underlying the CimetrATM-mediated anti-inflammatory
effect on human Peripheral Blood Mononuclear Cells (PBMC)
The study demonstrated the inhibitory effect of CimetrATM on the mRNA expression and,
as a result, on the secretion of IL-32 proteins and the subsequent suppression of
inflammation and inflammatory cytokines
Additional findings show that CimetrATM increases intracellular HO-1 the antioxidant
activity in cells, protecting against oxidative stress that causes the inflammation
Further demonstrates CimetrA
to be extended into the anti-inflammatory
MGC Pharmaceuticals Ltd (‘MGC Pharma’ or ‘the Company’) a European based pharmaceutical company specialising in the production and development of plant inspired medicines, has completed the pre-clinical study on CimetrATM, exploring the Mechanism of Action (MoA) of the product.
The study was conducted on human Peripheral Blood Mononuclear Cells (PBMC) crucial in the immune response, the results of which are consistent with previous reports. The administration of CimetrATM before and during Lipopolysaccharide (LPS) stimulation to produce an immune response and induce cytokine generation, resulted in a significant decrease in IL-32 mRNA expression and a resulting decrease in inflammation.
As such, we conclude that the presence of the IL-32 mRNA protein plays a critical role in the secretion of the cytokines (Figure 1), such as tumour necrosis factor-alpha (TNF-α) and IL-6 (Figure 2), that cause inflammation. Control of this protein is then the fundamental pathway to manage and reduce inflammation. The preclinical study demonstrates that the Mechanism of Action in MGC’s core development product, CimetrATM is the suppression of IL-32 protein via effect on the mRNA expression. The graph below demonstrates the decreased (up to undetectable values) IL-32A level after the treatment of the PBMC induced tissue with CimetrA in comparison with the baseline (LPS column), Placebo treatment and not treated control.

Link to article

Hi mate and all. I generally check in every few days and will remove any thrash when get chance.Hope all are well. I continue to build my pot here, it's a long term stock.Ta, Sam.
Keep up the good Samsung..you know its going up..you make me smile.
Go away, you vile cretin.
Not really Kenbos but just happy to be patient and see what happens.
Just dipped a toe with £1k (204k shares)...
Chat Pages: Latest  689  688  687  686  685  684  683  682  681  680  679  678  Older
Your Recent History
Mgc Pharma..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com

V: D: 20231003 01:33:32